Earnings expectation is settling
Expect $3.5bn CB dilutive effect to be short-term
1H24 VNB beat with margin recovery; expect total >US$7bn cash returns to shareholders in FY24
同庆楼(605108):Recovery in ‘Double Spring Year,’ Expect 2025 Profit to Improve
Expect a profit turnaround in 2023E
Overseas CXO/ life science upstream 2Q24 review: life science upstream continuing to expect demand recovery
China Technology Sector – Apple FY1Q23 miss on macro and supply chain issues; Expect weakness to persist in near term
Expecting bottoming out
SJM Holdings Expect catalyst
Optimized CoR guidance beat expectations